Crescent Biopharma Inc (CBIO) Stock Price, Quote, News & History

CBIONASDAQ
$19.41
-0.05-0.26%
At close: Sep 11, 5:00 PM EST
$19.41
N/A
After Hours: Sep 11, 4:00 PM EST

Crescent Biopharma (CBIO) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-72.68M
Investing Cash Flow (TTM)
-79.17M
Financing Cash Flow (TTM)
170.80M
Free Cash Flow (TTM)
-153.62M
Capital Expenditure (TTM)
-80.94M
Net Change in Cash (TTM)
18.95M

Analyst Trends and Forecast

1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$554.49M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
40.07
PB Ratio (TTM)
4.54
Earnings Yield % (TTM)
-0.72%
Earnings Yield % (FWD)
-23.65%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$4.29

Company Debt

Total Debt
-
LT Debt
-
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$171.59M
Debt to Equity
0.01
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$19.81
Close
$19.41
Volume / Avg.
264.45K / 336.08K
Day Range
$19.11 - $20.35
52 Wk Range
8.72 - 27.41
Market Cap
$720.96M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
58
Short Interest
14.66%
Days to Cover
19.91

About

Sector
Health Care
Industry
Biotechnology
Crescent Biopharma Inc is a biopharmaceutical company developing novel therapeutics to treat solid tumors, led by CR-001, a proprietary anti-PD-1/anti-VEGF bispecific antibody. Crescent's pipeline product CR-001 has the potential to deliver improved ...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Crescent Biopharma (CBIO) stock?

A

You can purchase shares of Crescent Biopharma (NASDAQ:CBIO) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Crescent Biopharma (CBIO) competitors?

Q

What is the forecast, or price target, for Crescent Biopharma (CBIO) stock?

A

Crescent Biopharma has a consensus price target of $27.60.

Q

What is the current price for Crescent Biopharma (CBIO)?

A

The stock price for Crescent Biopharma (NASDAQ: CBIO) is $19.41 last updated September 11, 2026 at 4:00 PM EDT.

Q

Does Crescent Biopharma (CBIO) pay a dividend?

A

There are no upcoming dividends for Crescent Biopharma.

Q

When is Crescent Biopharma (NASDAQ:CBIO) reporting earnings?

A

Crescent Biopharma does not have any upcoming earnings scheduled.

Q

Is Crescent Biopharma (CBIO) going to split?

A

There is no upcoming split for Crescent Biopharma.

Q

What sector and industry does Crescent Biopharma (CBIO) operate in?

A

Crescent Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.